News and Media

Latest News Release
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health Supports Future Pharmacists With More Than $625,000 In Scholarships
08/09/2013
Company Has Donated Nearly $2.2 Million to More Than 20 Universities Through Its Nationwide Pharmacy Scholarship Program, Now In Its Third Year

SEATTLE, Aug. 9, 2013 /PRNewswire/ -- As part of its continued commitment to supporting future pharmacists, Cardinal Health today announced that six pharmacy schools across the country will receive more than $625,000 in funding through the Cardinal Health Pharmacy Scholarship Program.

The company has donated nearly $2.2 million to more than 20 universities through this program since its launch in June 2011.   

The six schools that were selected to participate in this year's Cardinal Health Pharmacy Scholarship Program were selected based on their commitment to advancing the independent pharmacy profession. These schools offer curricula focused on operating an independent pharmacy; support student-run chapters of the National Community Pharmacists Association (NCPA); endorse internship and co-op programs with local independent retail pharmacies; and demonstrate high post-graduate placement rates in community pharmacy settings.

"Cardinal Health is dedicated to supporting the essential role community pharmacists play in delivering superior care to patients every day," said Mike Kaufmann, chief executive officer of Cardinal Health's Pharmaceutical Segment. "These universities are leaders in developing the future of independent pharmacy, and we're proud to support the growth and education of their best and brightest students."

The six schools that received pharmacy scholarship funding from the Cardinal Health Pharmacy Scholarship Program in 2013 include:

  • Chicago State College of Pharmacy (Chicago, Ill.) 
  • Drake University College of Pharmacy and Health Sciences (Des Moines, Iowa)
  • Nova Southeastern University College of Pharmacy (Puerto Rico)
  • The Ohio State University College of Pharmacy (Columbus, Ohio)
  • The South Carolina College of Pharmacy (Columbia, S.C.) 
  • The University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences (Aurora, Colo.) 

About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $101 billion health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers, clinical laboratories and physician offices focus on patient care while reducing costs, enhancing efficiency and improving quality. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products and services to more than 100,000 locations each day and is also the industry-leading direct-to-home medical supplies distributor. The company is a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company operates the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Ranked #19 on the Fortune 500, Cardinal Health employs 34,000 people worldwide. More information about the company may be found at www.cardinalhealth.com  and @CardinalHealth on Twitter.

SOURCE Cardinal Health

For further information: Media: Tara Schumacher, (614) 757-6250, Tara.Schumacher@cardinalhealth.com, or Investors: Kevin Moran, (614) 757-5035, Kevin.Moran@cardinalhealth.com
More Company News
03/26/2024

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2, prior to the opening of trading on the New York Stock Exchange. The company will...

03/15/2024

Cardinal Health (NYSE: CAH) today announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions...

02/29/2024

Study reveals impact of dramatic increase in commercially available biosimilars and progress in the areas of patient accessibility and treatment affordability DUBLIN, Ohio, Feb. 29, 2024...

02/28/2024

Cardinal Health (NYSE: CAH) announced today that its Board of Directors has elected Robert "Bob" Azelby as an independent director, effective March 1. Mr. Azelby joins the board with over 30 years...

View all company news »